Erythema Toxicum Neonatorum in Newborns and the Development of Asthma

Completed

• Conditions: Asthma; Erythema Toxicum Neonatorum

• Registration Number: NCT00178152
• Lead Sponsor: University of Rochester

Brief Summary

Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of research addressing this issue.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-15
• Primary Completion: 2005-11
• Study Completion: 2005-11
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-11
• Last Update Posted: 2011-05-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 334

Inclusion Criteria

• Children between the ages of 3-9 years who have had at least 2 asthma diagnoses within the last 2 years.
• Control subjects will be age matched and without an asthma diagnosis.

Exclusion Criteria

• Children without accessible medical records

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Department of Pediatrics, University of Rochester; 🇺🇸 Rochester, New York, United States